Dr Nantni Kumaran

Moderator: Prof Shahnaz Hasan

13 Sept 2024

1.  TXA is a potent antifibrinolytic with recognized efficacy in several
   clinical settings.
2. In the perioperative arena, TXA continues to be used as one
   component of routine blood conservation strategies.
3. Studies and trial done to date may ultimately help determine the
   most appropriate dose and timing of TXA to achieve optimal haemostatic outcomes in different clinical settings.

Click Here